Dr. Jordan Kharofa
Claim this profileUniversity of Cincinnati Cancer Center-UC Medical Center
Studies Cancer
Studies Colorectal Cancer
10 reported clinical trials
21 drugs studied
Area of expertise
1Cancer
Stage II
Stage III
Stage IV
2Colorectal Cancer
Stage IV
Stage III
Stage II
Affiliated Hospitals
Clinical Trials Jordan Kharofa is currently running
Proton vs Photon Therapy
for Liver Cancer
This phase III trial studies how well radiation therapy with protons works compared with photons in treating patients with liver cancer. Radiation therapy, such as photon therapy, uses high energy x-rays to send the radiation inside the body to the tumor while proton therapy uses a beam of proton particles. Proton therapy can stop shortly after penetrating through the tumor and may cause less damage to the surrounding healthy organs and result in better survival in patients with liver cancer.
Recruiting2 awards Phase 3
Chemotherapy + Bevacizumab + Atezolizumab
for Colorectal Cancer
This phase III trial studies how well combination chemotherapy, bevacizumab, and/or atezolizumab work in treating patients with deficient deoxyribonucleic acid (DNA) mismatch repair colorectal cancer that has spread from where it first started (primary site) to other places in the body (metastatic). Chemotherapy drugs, such as fluorouracil, oxaliplatin, and leucovorin calcium, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Bevacizumab may stop or slow colorectal cancer by blocking the growth of new blood vessels necessary for tumor growth. Immunotherapy with monoclonal antibodies, such as atezolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Giving combination chemotherapy, bevacizumab, and atezolizumab may work better in treating patients with colorectal cancer.
Recruiting2 awards Phase 31 criteria
More about Jordan Kharofa
Clinical Trial Related6 years of experience running clinical trials · Led 10 trials as a Principal Investigator · 5 Active Clinical TrialsTreatments Jordan Kharofa has experience with
- Fluorouracil
- Intensity-Modulated Radiation Therapy
- Cisplatin
- Proton Beam Radiation Therapy
- Capecitabine
- Gemcitabine Hydrochloride
Breakdown of trials Jordan Kharofa has run
Cancer
Colorectal Cancer
Anal Cancer
Squamous Cell Carcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Jordan Kharofa specialize in?
Jordan Kharofa focuses on Cancer and Colorectal Cancer. In particular, much of their work with Cancer has involved Stage II patients, or patients who are Stage III.
Is Jordan Kharofa currently recruiting for clinical trials?
Yes, Jordan Kharofa is currently recruiting for 5 clinical trials in Cincinnati Ohio. If you're interested in participating, you should apply.
Are there any treatments that Jordan Kharofa has studied deeply?
Yes, Jordan Kharofa has studied treatments such as Fluorouracil, Intensity-Modulated Radiation Therapy, Cisplatin.
What is the best way to schedule an appointment with Jordan Kharofa?
Apply for one of the trials that Jordan Kharofa is conducting.
What is the office address of Jordan Kharofa?
The office of Jordan Kharofa is located at: University of Cincinnati Cancer Center-UC Medical Center, Cincinnati, Ohio 45219 United States. This is the address for their practice at the University of Cincinnati Cancer Center-UC Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.